{
    "2021-01-29": [
        [
            {
                "time": "",
                "original_text": "甘李药业：在研药GLR2007获FDA快速通道认定 研发进程再提速",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GLR2007",
                        "FDA",
                        "快速通道",
                        "研发进程"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：在研产品GLR2007获美国FDA快速通道资格",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GLR2007",
                        "美国FDA",
                        "快速通道",
                        "在研产品"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}